Literature DB >> 11090599

Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.

W W Winder1, B F Holmes.   

Abstract

Fatty acid oxidation in muscle has been reported to be diminished when insulin and glucose levels are elevated. This study was designed to determine whether activation of AMP-activated protein kinase (AMPK) will prevent inhibitory effects of insulin and glucose on the rate of fatty acid oxidation. Rat hindlimbs were perfused with medium containing 0, 0.3, or 60 nM insulin with or without 2 mM 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Glucose uptake was stimulated four- to fivefold by inclusion of insulin in the medium. Insulin attenuated the increase in AMPK caused by AICAR both in perfused hindlimbs and in isolated epitrochlearis muscles. The activation constant for citrate activation of acetyl-CoA carboxylase (ACC) was significantly increased in response to AICAR, and the increase was slightly attenuated if insulin was present in the perfusion medium. Insulin stimulated an increase in malonyl-CoA content of the muscles in the absence of AICAR. Malonyl-CoA was decreased to approximately the same value in AICAR-perfused muscle, regardless of insulin concentration. Muscle glucose 6-phosphate and citrate were significantly increased in response to AICAR and insulin. The rate of palmitate oxidation tended to decrease in response to insulin and in the absence of AICAR. AICAR increased palmitate oxidation to approximately the same level regardless of the insulin concentration or the rate of glucose uptake into the muscle. The rate of palmitate oxidation showed a curvilinear relationship as a function of muscle malonyl-CoA content, with half-maximal inhibition at approximately 0.6 nmol/g. We conclude that AMPK activation can prevent high rates of glucose uptake and glycolytic flux from inhibiting palmitate oxidation in predominantly fast-twitch muscle under these conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090599     DOI: 10.1152/jappl.2000.89.6.2430

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

1.  Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats.

Authors:  Feng-Hao Geng; Guo-Hua Li; Xing Zhang; Peng Zhang; Ming-Qing Dong; Zhi-Jing Zhao; Yuan Zhang; Ling Dong; Feng Gao
Journal:  Br J Pharmacol       Date:  2016-04-05       Impact factor: 8.739

2.  Do blood cells mimic gene expression profile alterations known to occur in muscular adaptation to endurance training?

Authors:  J Zeibig; H Karlic; A Lohninger; R Damsgaard; R Dumsgaard; G Smekal
Journal:  Eur J Appl Physiol       Date:  2005-04-07       Impact factor: 3.078

3.  α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase.

Authors:  W-L Chen; C-H Kang; S-G Wang; H-M Lee
Journal:  Diabetologia       Date:  2012-03-30       Impact factor: 10.122

4.  Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen.

Authors:  Glenn K McConell; Robert S Lee-Young; Zhi-Ping Chen; Nigel K Stepto; Ngan N Huynh; Terry J Stephens; Benedict J Canny; Bruce E Kemp
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

Review 5.  Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise.

Authors:  Sebastian B Jørgensen; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

6.  Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio.

Authors:  Qingqing Liu; Marie-Soleil Gauthier; Lei Sun; Neil Ruderman; Harvey Lodish
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

Review 7.  AMP-activated protein kinase control of fat metabolism in skeletal muscle.

Authors:  D M Thomson; W W Winder
Journal:  Acta Physiol (Oxf)       Date:  2009-02-19       Impact factor: 6.311

8.  Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.

Authors:  Kaio F Vitzel; George Bikopoulos; Steven Hung; Kathryn E Pistor; Jessica D Patterson; Rui Curi; Rolando B Ceddia
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  Role of AMPK α in skeletal muscle glycometabolism regulation and adaptation in relation to sepsis.

Authors:  Xia Zheng; Mi Xu; Qiang Fang
Journal:  Biomed Res Int       Date:  2014-06-29       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.